103 Views

Session: Precision Medicine for the Surgical Oncologist: Current and Future Strategies

Molecular Profiling to Personalize Therapies for Advanced Cancer: Successes, Failures, and Current Trials

Thursday, March 10, 2022

3:03 PM – 3:23 PM CST

Location: Coronado

Presenter(s)

Jason Sicklick, MD

Professor of Surgery
UC San Diego Moores Cancer Center
La Jolla, CA, United States

Disclosure: Amgen (Individual(s) Involved: Self): Philanthropic research donation, Research Support; Deciphera (Individual(s) Involved: Self): Consultant, Speaker/Honoraria; Foundation Medicine, Inc. (Individual(s) Involved: Self): Speaker/Honoraria; La Hoffman-Roche (Individual(s) Involved: Self): Speaker/Honoraria; Merck (Individual(s) Involved: Self): Speaker/Honoraria; MJH Life Sciences (Individual(s) Involved: Self): Speaker/Honoraria; Personalis (Individual(s) Involved: Self): Stockholder; QED Therapeautics (Individual(s) Involved: Self): Speaker/Honoraria

Participants should be aware of the following financial/non-financial relationships:

Jason Sicklick, MD: Amgen (Individual(s) Involved: Self): Philanthropic research donation, Research Support; Deciphera (Individual(s) Involved: Self): Consultant, Speaker/Honoraria; Foundation Medicine, Inc. (Individual(s) Involved: Self): Speaker/Honoraria; La Hoffman-Roche (Individual(s) Involved: Self): Speaker/Honoraria; Merck (Individual(s) Involved: Self): Speaker/Honoraria; MJH Life Sciences (Individual(s) Involved: Self): Speaker/Honoraria; Personalis (Individual(s) Involved: Self): Stockholder; QED Therapeautics (Individual(s) Involved: Self): Speaker/Honoraria

SSO 2022’s program features four Great Debates on controversial topics and ten symposia sessions that span several diseases and perspectives.